Procept Biorobotics CORP Schedule 13G passive stakes

AllianceBernstein L.P. has filed a Schedule 13G, reporting beneficial ownership of 147,327 shares of PROCEPT BioRobotics Corp. common stock, representing 0.3% of the class.

Vanguard Capital Management has reported beneficial ownership of 5% of PROCEPT BioRobotics Corp. common stock as of March 31, 2026.

The Vanguard Group reported 0% beneficial ownership in PROCEPT BioRobotics Corp following an internal realignment and disaggregated reporting strategy.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 2.9% in PROCEPT BIOROBOTICS CORP, indicating a reduction from previous holdings.

T. Rowe Price Investment Management, Inc. reports a 5.9% beneficial ownership stake in PROCEPT BIOROBOTICS CORP common stock.

BNP Paribas Asset Management Holding S.A. has reported a 5.5% beneficial ownership stake in PROCEPT BioRobotics Corp, totaling 3,094,649 shares of common stock.

FMR LLC and Abigail P. Johnson reported an 8.3% beneficial ownership stake in PROCEPT BioRobotics Corp, holding over 4.6 million common shares as of December 31, 2025.

AllianceBernstein L.P. has reported a 6.1% beneficial ownership stake in PROCEPT BioRobotics Corp, holding 3,419,784 shares for investment purposes.